Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells

Asian Journal of Andrology

Volumn 14, Issue 5, 2012, Pages 745-751

  Darrington, Eric ^a   Zhong, Miao ^a   Vo, Bao Han ^a   Khan, Shafiq A ^a  

^a CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

cell migration; hypoxia; prostate cancer; transforming growth factor b1 (TGF b1); vascular endothelial growth factor A (VEGFA)

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; METASTASIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BLOTTING, WESTERN; CELL HYPOXIA; DNA PRIMERS; HUMANS; MALE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84866265028     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.197     Document Type: Article

References (33)

1. Ferrara N Gerber HP LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
2. Soker S Takashima S Miao HQ Neufeld G Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92: 735-45.
3. de Vries C Escobedo JA Ueno H Houck K Ferrara N et al. The fms-like tyrosine kinase a receptor for vascular endothelial growth factor. Science 1992; 255: 989- 91.
4. Terman BI Dougher-Vermazen M Carrion ME Dimitrov D Armellino DC et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579-86.
5. Lichtenberger BM Tan PK Niederleithner H Ferrara N Petzelbauer P et al. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 2010; 140: 268-79.
6. Maxwell PH Dachs GU Gleadle JM Nicholls LG Harris AL et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1997; 94: 8104-9.
7. Dunn LK Mohammad KS Fournier PG McKenna CR Davis HW et al. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One 2009; 4: E6896.
8. Sanchez-Elsner T Botella LM Velasco B Corbi A Attisano L et al. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001; 276: 38527-35.
9. Cunha SI Pardali E Thorikay M Anderberg C Hawinkels L et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med 2010; 207: 85-100.
10. Patel B Khaliq A Jarvis-Evans J McLeod D Mackness M et al. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int 1994; 34: 639-44.
11. Warren SM Steinbrech DS Mehrara BJ Saadeh PB Greenwald JA et al. Hypoxia regulates osteoblast gene expression. J Surg Res 2001; 99: 147-55.
12. Duque JL Loughlin KR Adam RM Kantoff PW Zurakowski D et al. Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology 1999; 54: 523-7.
13. Pallares J Rojo F Iriarte J Morote J Armadans LI et al. Study of microvessel density and the expression of the angiogenic factors VEGF bFGF and the receptors Flt-1 and FLK-1 in benign premalignant and malignant prostate tissues. Histol Histopathol 2006; 21: 857-65.
14. Sweeney P Karashima T Kim SJ Kedar D Mian B et al. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Clin Cancer Res 2002; 8: 2714-24.
15. Soker S Kaefer M Johnson M Klagsbrun M Atala A et al. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol 2001; 159: 651-9.
16. De S Chen J Narizhneva NV Heston W Brainard J et al. Molecular pathway for cancer metastasis to bone. J Biol Chem 2003; 278: 39044-50.
17. Zhang S Zhau HE Osunkoya AO Iqbal S Yang X et al. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol Cancer 2010; 9: 9.
18. Zhong M Boseman ML Millena AC Khan SA. Oxytocin induces the migration of prostate cancer cells: Involvement of the Gi-coupled signaling pathway. Mol Cancer Res 2010; 8: 1164-72.
19. Zhong M Navratil AM Clay C Sanborn BM. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function. Biochemistry 2004; 43: 3490-8.
20. Chae KS Kang MJ Lee JH Ryu BK Lee MG et al. Opposite functions of HIF-alpha isoforms in VEGF induction by TGF-beta1 under non-hypoxic conditions. Oncogene 2011; 30: 1213-28.
21. Laping NJ Grygielko E Mathur A Butter S Bomberger J et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002; 62: 58-64.
22. Aiello LP Pierce EA Foley ED Takagi H Chen H et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A 1995; 92: 10457-61.
23. Kubo K Shimizu T Ohyama S Murooka H Iwai A et al. Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: Synthesis structure-activity relationships and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)- phenyl}ureas. J Med Chem 2005; 48: 1359-66.
24. Nanni S Benvenuti V Grasselli A Priolo C Aiello A et al. Endothelial NOS estrogen receptor beta and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest 2009; 119: 1093-108.
25. Eastham JA Truong LD Rogers E Kattan M Flanders KC et al. Transforming growth factor-beta 1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest 1995; 73: 628-35.
26. Pardali K Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007; 1775: 21-62.
27. Tuomela J Valta M Seppanen J Tarkkonen K Vaananen HK et al. Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer 2009; 9: 362.
28. Wong SY Haack H Crowley D Barry M Bronson RT et al. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 2005; 65: 9789-98.
29. Clavin NW Avraham T Fernandez J Daluvoy SV Soares MA et al. TGF-beta1 is Negative Regulator Of Lymphatic Regeneration During Wound Repair. Am J Physiol Heart Circ Physiol 2008; 295 H2113-27.
30. Enholm B Paavonen K Ristimaki A Kumar V Gunji Y et al. Comparison of VEGF VEGF-B VEGF-C and Ang-1 mRNA regulation by serum growth factors oncoproteins and hypoxia. Oncogene 1997; 14: 2475-83.
31. Connolly JM Rose DP. Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J Urol 1998; 160: 932-6.
32. Mak P Leav I Pursell B Bae D Yang X et al. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: Implications for Gleason grading. Cancer Cell 2010; 17: 319-32.
33. Hurlbut GD KankelMW,Artavanis-Tsakonas S. Nodal points and complexity of Notch- Ras signal integration. Proc Natl Acad Sci U S A 2009; 106: 2218-23.